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EDITORIALSound the Alarmin: Interleukin-33 Commandeers the Gastric
Immune Responsenterleukin-33 (IL-33) is a member of the IL-1 super-Ifamily and activates group 2 innate lymphoid cells
(ILC2), mast cells, and their progenitors. Studies indicate
that ILCs, which secrete copious amounts of IL-5 and IL-13
in response to IL-33, play critical roles in directing the
development of type-2 immunity and allergic inﬂammation.
In this issue of Cellular and Molecular Gastroenterology and
Hepatology, Buzzelli et al1 provide novel insights into the
role that IL-33 exerts on the gastric immune response to
infection with the pathogen Helicobacter pylori.
Chronic H. pylori-induced gastritis is mediated by a
variety of constituents, including gastric epithelial cells,
neutrophils, macrophages, and dendritic cells that lead to
a TH1-biased lymphocyte response. One microbial deter-
minant that augments gastric cancer risk is the cag path-
ogenicity island, and cagþ strains signiﬁcantly increase the
risk for severe gastritis, atrophic gastritis, and cancer
compared with strains lacking the cag island.2 Another
H. pylori factor, neutrophil-activating protein, promotes
neutrophil recruitment, contributes to TH1 polarization by
stimulating both IL-12 and IL-23, and inﬂuences the pro-
duction of TH1 cells, resulting in increased production of
interferon-g (IFN-g), tumor necrosis factor-a (TNF-a), and
cytolytic activity of T helper (TH) cells.
3 H. pylori also ac-
tivates macrophages, resulting in the production of IL-1
and TNF-a,4 in turn, promoting a TH1-directed response.
Dendritic cells (DCs) represent a critical bridge between
the innate and adaptive immune responses. In response to
H. pylori, DCs drive TH1-effector responses, leading to
production of TNF-a, IFN-g, and IL-2.5 Consistent with a
TH1-type cytokine response, gastric lymphocyte pop-
ulations from H. pylori-infected patients harbor IFN-g-
producing T cells; after stimulation, these cells produce
abundant levels of the TH1 cytokines IFN-g and IL-2 and
low levels of the TH2 cytokines IL-4 and IL-5.
6 Collectively,
the host immune response to H. pylori is predominantly a
TH1-type response, which leads to the development of a
chronic inﬂammatory inﬁltrate that fails to eliminate this
pathogen.
Buzzelli et al demonstrate that IL-33 expression is
increased in response to acute H. pylori infection but is
reciprocally suppressed during chronic H. pylori infection in
mice and humans, which contributes to the dominant TH1-
polarized phenotype observed within infected gastric mu-
cosa. To deﬁne the gastric response to IL-33 per se, mice
were treated with recombinant IL-33. Chronic IL-33
administration led to increased gastric inﬂammation and
the development of atrophy and metaplasia. Using ﬂow
cytometry to characterize immune cell populations in
response to IL-33, the authors demonstrated no differencesCelluin the number of lymphocytes, but noted a signiﬁcant
expansion of myeloid-derived immunocytes, including
macrophages, myeloid-derived suppressor cells, neutro-
phils, and DCs. IL-33 has been previously shown to activate
ILC2, TH2 immunocytes, and a TH2 cytokine response, and
chronic IL-33 administration results in increased expression
of ILC2 markers and the TH2 cytokine IL-4 in the stomach.
Conversely, concomitant infection with H. pylori suppressed
IL-33 production, which corresponded to decreased
expression of ILC2 markers.
This study provides novel ﬁndings regarding the role of
IL-33 in gastric immune responses, but more importantly, it
has established a framework for future studies in this ﬁeld.
The authors demonstrate that IL-33 expression is increased
with increasing bacterial abundance and diversity. This is
noteworthy when viewed within the context of H. pylori
infection, as infection with H. pylori leads to a decrease in
the diversity of gastric microbial communities.7 Thus, the
diversity of the microbiome, in conjunction with a bacterial
pathogen, may contribute to the complex regulation of
IL-33.
The authors also demonstrate that expression of IL-33 in
the stomach is partially regulated by TFF2. H. pylori up-
regulates TFF2 in gastric tissue in both humans and mice,
and loss of TFF2 expression in vivo results in a signiﬁcant
increase in H. pylori-induced IFN-g production, gastric
inﬂammation, atrophy, metaplasia, and dysplasia,8 which
may be related to TFF2-mediated regulation of IL-33. What
could account for the ability of IL-33 alone to induce gastric
atrophy and metaplasia, lesions that are also induced by
H. pylori? Based on the dramatic and divergent expression
pattern of IL-33 in response to H. pylori, follow-up studies
should focus on additional host factors that regulate IL-33
expression in the stomach.
In terms of microbial determinants, the authors
demonstrate that the H. pylori strain SS1 induces IL-33
during acute infection but suppresses IL-33 during chronic
infection in mice. Because SS1 lacks a functional cag type IV
secretion system, these data suggest that H. pylori strains
that harbor a functional cag secretion system could differ-
entially regulate IL-33 expression, which can be easily
tested. Future studies that investigate mechanisms by which
H. pylori temporally activates and suppresses IL-33
expression will be crucial in understanding immune re-
sponses to this gastric pathogen.
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